Hormone Therapy for Cancer Is a Risk Factor for Relapse of Inflammatory Bowel Diseases.
Axelrad JE, Bazarbashi A, Zhou J, Castañeda D, Gujral A, Sperling D, Glass J, Agrawal M, Hong S, Lawlor G, Hudesman D, Chang S, Shah S, Yajnik V, Ananthakrishnan A, Khalili H, Colombel JF, Itzkowitz S; New York Crohn’s and Colitis Organization.
Axelrad JE, et al. Among authors: agrawal m.
Clin Gastroenterol Hepatol. 2020 Apr;18(4):872-880.e1. doi: 10.1016/j.cgh.2019.06.042. Epub 2019 Jul 11.
Clin Gastroenterol Hepatol. 2020.
PMID: 31302306
Free PMC article.